Tenax Therapeutics CEO Anthony DiTonno's 2021 pay jumps 44% to $1.1M

Tenax Therapeutics reports 2021 executive compensation

By ExecPay News

Published: April 28, 2022

Tenax Therapeutics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, five executives at Tenax Therapeutics received on average a compensation package of $749K, a 13% increase compared to previous year.
Average pay of disclosed executives at Tenax Therapeutics
Anthony A. DiTonno, Chief Executive Officer, received $1.1M in total, which increased by 44% compared to 2020.
Michael B. Jebsen, Chief Financial Officer, received a compensation package of $980K, which increased by 64% compared to previous year. 41% of the compensation package, or $403K, was in other compensation.
Christopher T. Giordano, Chief Executive Officer, earned $861K in 2021.
Stuart Rich, Chief Medical Officer, received $818K in 2021.
Eliot M. Lurier, Chief Financial Officer, earned $26K in 2021.

Related executives

Christopher Giordano

Tenax Therapeutics

Chief Executive Officer

Eliot Lurier

Tenax Therapeutics

Chief Financial Officer

Stuart Rich

Tenax Therapeutics

Chief Medical Officer

Anthony DiTonno

Tenax Therapeutics

Chief Executive Officer

Michael Jebsen

Tenax Therapeutics

Chief Financial Officer

You may also like

Source: SEC filing on April 28, 2022.